24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          The aim of this study was to evaluate the usefulness of magnetic resonance imaging ( MRI) in detecting the progression of Duchenne muscular dystrophy ( DMD) by quantification of fat infiltration ( FI) and muscle volume index ( MVI, a residual‐to‐total muscle volume ratio).

          Methods

          Twenty‐six patients (baseline age: 5–12 years) with genetically proven DMD were longitudinally analyzed with lower limb 3T MRI, force measurements, and functional tests (Gowers, 10‐m time, North Star Ambulatory Assessment, 6‐min walking test). Five age‐matched controls were also examined, with a total of 85 MRI studies. Semiquantitative (scores) and quantitative MRI ( qMRI) analyses (signal intensity ratio – SIR, lower limb MVI, and individual muscle MVI) were carried out. Permutation and regression analyses according to both age and functional test‐outcomes were calculated. Age‐related quantitative reference curves of SIRs and MVIs were generated.

          Results

          FI was present on glutei and adductor magnus in all patients since the age of 5, with a proximal‐to‐distal progression and selective sparing of sartorius and gracilis. Patients' qMRI measures were significantly different from controls' and among age classes. qMRI were more sensitive than force measurements and functional tests in assessing disease progression, allowing quantification also after loss of ambulation. Age‐related curves with percentile values were calculated for SIRs and MVIs, to provide a reference background for future experimental therapy trials. SIRs and MVIs significantly correlated with all clinical measures, and could reliably predict functional outcomes and loss of ambulation.

          Interpretations

          qMRI‐based indexes are sensitive measures that can track the progression of DMD and represent a valuable tool for follow‐up and clinical studies.

          Related collections

          Most cited references23

          • Record: found
          • Abstract: found
          • Article: not found

          Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts.

          Preclinical or clinical trials for muscular dystrophies have met with modest success, mainly because of inefficient delivery of viral vectors or donor cells to dystrophic muscles. We report here that intra-arterial delivery of wild-type mesoangioblasts, a class of vessel-associated stem cells, corrects morphologically and functionally the dystrophic phenotype of virtually all downstream muscles in adult immunocompetent alpha-sarcoglycan (alpha-SG) null mice, a model organism for limb-girdle muscular dystrophy. When mesoangioblasts isolated from juvenile dystrophic mice and transduced with a lentiviral vector expressing alpha-SG were injected into the femoral artery of dystrophic mice, they reconstituted skeletal muscle in a manner similar to that seen in wild-type cells. The success of this protocol was mainly due to widespread distribution of donor stem cells through the capillary network, a distinct advantage of this strategy over previous approaches.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.

            Attempts to develop gene therapy for Duchenne muscular dystrophy (DMD) have been complicated by the enormous size of the dystrophin gene. We have performed a detailed functional analysis of dystrophin structural domains and show that multiple regions of the protein can be deleted in various combinations to generate highly functional mini- and micro-dystrophins. Studies in transgenic mdx mice, a model for DMD, reveal that a wide variety of functional characteristics of dystrophy are prevented by some of these truncated dystrophins. Muscles expressing the smallest dystrophins are fully protected against damage caused by muscle activity and are not morphologically different from normal muscle. Moreover, injection of adeno-associated viruses carrying micro-dystrophins into dystrophic muscles of immunocompetent mdx mice results in a striking reversal of histopathological features of this disease. These results demonstrate that the dystrophic pathology can be both prevented and reversed by gene therapy using micro-dystrophins.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Muscle MRI in inherited neuromuscular disorders: past, present, and future.

              Interest in muscle MRI has been largely stimulated in the last few years by the recognition of an increasing number of genetic defects in the field of inherited neuromuscular disorders. Muscle ultrasound (US) and computed tomography (CT) have been used to detect the presence of muscle involvement in patients affected by these disorders, but until recently the use of muscle MRI has been, with a few exceptions, limited to detecting inflammatory forms. The aim of this review is to illustrate how muscle MRI, in combination with clinical evaluation, can contribute to the selection of appropriate genetic tests and more generally in the differential diagnosis of genetically distinct forms of neuromuscular disorders. Possible future applications of muscle MRI are also discussed. (c) 2007 Wiley-Liss, Inc.
                Bookmark

                Author and article information

                Journal
                Ann Clin Transl Neurol
                Ann Clin Transl Neurol
                10.1002/(ISSN)2328-9503
                ACN3
                Annals of Clinical and Translational Neurology
                John Wiley and Sons Inc. (Hoboken )
                2328-9503
                16 June 2016
                August 2016
                : 3
                : 8 ( doiID: 10.1111/acn3.2016.3.issue-8 )
                : 607-622
                Affiliations
                [ 1 ] Neuroradiology DepartmentNeuroradiology Research Group and CERMAC San Raffaele Scientific Institute and Vita‐Salute San Raffaele University MilanItaly
                [ 2 ] CUSSBUniversity Centre for Biomedical Sciences Vita‐Salute San Raffaele University MilanItaly
                [ 3 ] Laboratory of Analysis and Rehabilitation of Motor Function Division of NeuroscienceSan Raffaele Scientific Institute MilanItaly
                [ 4 ] Division of NeuroscienceInstitute of Experimental Neurology (INSpe) San Raffaele Scientific Institute MilanItaly
                [ 5 ] San Raffaele Telethon Institute for Gene Therapy (HSR‐TIGET) and Pediatric Immunohematology and Bone Marrow Transplantation Unit San Raffaele Scientific Institute MilanItaly
                [ 6 ] Stem Cell Laboratory Department of Pathophysiology and TransplantationUniversitá degli Studi di Milano Fondazione IRCCS Cá Granda Ospedale Maggiore Policlinico Centro Dino Ferrari, MilanItaly
                [ 7 ] Radiology DepartmentSan Raffaele Scientific Institute and Vita‐Salute San Raffaele University MilanItaly
                [ 8 ] Hematology and BMT UnitSan Raffaele Scientific Institute and Vita‐Salute San Raffaele University MilanItaly
                [ 9 ] Institute of Inflammation and RepairUniversity of Manchester ManchesterUnited Kingdom
                [ 10 ] Neuroimaging Research Division of Hematology/OncologyBoston Children's Hospital Boston MAUSA
                [ 11 ] Department of PediatricsHarvard Medical School Boston MAUSA
                [ 12 ]University of Massachusetts Memorial Medical Center and University of Massachusetts Medical School Worcester MAUSA
                Author notes
                [*] [* ] Correspondence

                Letterio S. Politi, Neuroradiology Department, Neuroradiology Research Group and CERMAC, San Raffaele Scientific Institute and Vita‐Salute San Raffaele University, Via Olgettina 60, 20132 Milan, Italy. Tel: +39 348 3221188; Fax: +39 02 2643 3447; E‐mail: politi.letterio@ 123456hsr.it

                and

                Yvan Torrente, Stem Cell Laboratory, Department of Pathophysiology and Transplantation, Universitá degli Studi di Milano, Fondazione IRCCS Cá Granda Ospedale Maggiore Policlinico, Centro Dino Ferrari, via Francesco Sforza 35, 20122 Milan, Italy. Tel: +39 02 55033874; Fax: +39 02 55034723; E‐mail: yvan.torrente@ 123456unimi.it

                Author information
                http://orcid.org/0000-0003-1330-1673
                http://orcid.org/0000-0003-1976-5663
                Article
                ACN3319
                10.1002/acn3.319
                4999593
                27606343
                764ca92f-1f73-4714-838d-6ba13b1e047d
                © 2016 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.

                This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 11 March 2016
                : 22 April 2016
                : 30 April 2016
                Page count
                Pages: 16
                Funding
                Funded by: Associazione Amici Centro Dino Ferrari
                Funded by: Italian Ministry of Health
                Award ID: RF‐2009‐1547384
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                acn3319
                August 2016
                Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.4 mode:remove_FC converted:26.08.2016

                Comments

                Comment on this article